AKT2 is a well-known target for cancer treatment, and we have demonstrated its importance for CSC growth and dynamism in breast cell lines, suggesting that AKT2 could be an ideal candidate for an effective anti-cancer therapy [12,30]. This evidence concerns the gene AKT2 and cancer.